7 Results

People

  1. Agus
    Agus
  2. Scher
    Scher
  3. Cordon-Cardo
    Cordon-Cardo
  4. Drobnjak
    Drobnjak
  5. Golde
    Golde
  6. Heller
    Heller
  7. Higgins
    Higgins
  8. Morris
    Morris
  9. Ballangrud-Popovic
    Ballangrud-Popovic
  10. Berg
    Berg

Groups

  1. Department of Medicine (7)
  2. Genitourinary Oncology Service (7)
  3. Solid Tumor Oncology Division (7)
  4. Biostatistics Service (2)
  5. Epidemiology and Biostatistics (2)
  6. GSK Faculty (2)
  7. Sloan Kettering Institute Faculty (2)
  8. Breast Medicine Service (1)
  9. Center for Hematologic Malignancies (1)
  10. Hematologic Malignancies, Division of (1)
  1. "humans"
  2. "Howard Scher"
  3. "David Agus"
Formats
  1. Journal Article (7)
Groups
  1. Department of Medicine (7)
  2. Genitourinary Oncology Service (7)
  3. Solid Tumor Oncology Division (7)
  4. Biostatistics Service (2)
  5. Epidemiology and Biostatistics (2)
  6. GSK Faculty (2)

More Groups

People
  1. David Agus (7)
  2. Howard Scher (7)
  3. Carlos Cordon-Cardo (5)
  4. Marija Drobnjak (4)
  5. Brian Higgins (2)
  6. David Golde (2)

More People

Years
  1. 2004 (1)
  2. 2002 (1)
  3. 2001 (2)
  4. 2000 (1)
  5. 1999 (1)
  6. 1998 (1)
Publications
  1. Clinical Cancer Research (3)
  2. Cancer Research (2)
  3. JNCI: Journal of the National Cancer Institute (1)
  4. Journal of Clinical Oncology (1)
Publishers
  1. American Association for Cancer Research (5)
  2. American Society of Clinical Oncology (1)
  3. Oxford University Press (1)

Results (7)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Eligibility and outcomes reporting guidelines for clinical trials for patients in the state of a rising prostate-specific antigen: Recommendations from the Prostate-Specific Antigen Working Group
    Journal Article

    Scher, H. I.; Eisenberger, M.; D'Amico, A. V.; Halabi, S.; Small, E. J.; Morris, M.; Kattan, M. W.; Roach, M.; Kantoff, P.; Pienta, K. J.; more...
    Journal of Clinical Oncology (2004)

    Fulltext@MSK | Save
  • 17-Allylamino-17-demethoxygeldanamycin induces the degradation of androgen receptor and HER-2/neu and inhibits the growth of prostate cancer xenografts
    Journal Article

    Solit, D. B.; Zheng, F. F.; Drobnjak, M.; Mùˆnster, P. N.; Higgins, B.; Verbel, D.; Heller, G.; Tong, W.; Cordon-Cardo, C.; Agus, D. B.; more...
    Clinical Cancer Research (2002)

    Fulltext@MSK | Save
  • HER-2/neu (p185neu) protein expression in the natural or treated history of prostate cancer
    Journal Article

    Osman, I.; Scher, H. I.; Drobnjak, M.; Verbel, D.; Morris, M.; Agus, D.; Ross, J. S.; Cordon-Cardo, C.
    Clinical Cancer Research (2001)

    Fulltext@MSK | Save
  • Inhibition of transformed cell growth and induction of cellular differentiation by pyroxamide, an inhibitor of histone deacetylase
    Journal Article

    Butler, L. M.; Webb, Y.; Agus, D. B.; Higgins, B.; Tolentino, T. R.; Kutko, M. C.; LaQuaglia, M. P.; Drobnjak, M.; Cordon-Cardo, C.; Scher, H. I.; more...
    Clinical Cancer Research (2001)

    Fulltext@MSK | Save
  • Ligand responsiveness in human prostate cancer: Structural analysis of mutant androgen receptors from LNCaP and CWR22 tumors
    Journal Article

    Mcdonald, S.; Brive, L.; Agus, D. B.; Scher, H. I.; Ely, K. R.
    Cancer Research (2000)

    Fulltext@MSK | Save
  • Prostate cancer cell cycle regulators: Response to androgen withdrawal and development of androgen independence
    Journal Article

    Agus, D. B.; Cordon-Cardo, C.; Fox, W.; Drobnjak, M.; Koff, A.; Golde, D. W.; Scher, H. I.
    JNCI: Journal of the National Cancer Institute (1999)

    Fulltext@MSK | Save
  • Positron emission tomography of a human prostate cancer xenograft: Association of changes in deoxyglucose accumulation with other measures of outcome following androgen withdrawal
    Journal Article

    Agus, D. B.; Golde, D. W.; Sgouros, G.; Ballangrud, A.; Cordon-Cardo, C.; Scher, H. I.
    Cancer Research (1998)

    Fulltext@MSK | Save